Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Markham’s new gig

Executive Summary

Former Aventis Vice Chairman and Chief Operating Officer Richard Markham joins Care Capital, a Princeton, N.J.-based venture capital firm focusing on later stage investments. Markham was one of several Aventis senior executives to depart after the company was acquired by Sanofi (1"The Pink Sheet" Sept. 6, 2004, p. 3). He joins former SmithKline Beecham CEO Jan Leschly and Novartis CEO-Pharmaceuticals Jerry Karabelas, PhD, who both serve as partners of the venture capital firm. Prior to Markham's tenure at Aventis (and predecessor companies), he spent 20 years at Merck and was the company's first choice to replace CEO Roy Vagelos, MD, when he retired in 1993; he could be an intriguing choice to replace CEO Ray Gilmartin when he retires in 2006 (2"The Pink Sheet" Oct. 18, 2004, p. 4). However, Markham said he intends to remain in the venture capital industry on a permanent basis...
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS045006

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel